Chinese medicinal compound preparation for treating uterine myoma

Abstract

The invention discloses a Chinese medicinal compound preparation for treating uterine myoma. The Chinese medicinal compound preparation consists of a preparation for oral administration and a preparation for external application, wherein the preparation for oral administration comprises the following components in part by weight: 5 to 15 parts of Chinese angelica, 5 to 15 parts of szechuan lovage rhizome, 5 to 15 parts of rehmanniae vaporata, 5 to 15 parts of white paeony root, 6 to 18 parts of salivia chinensis, 6 to 18 parts of fibrous ginseng root, 5 to 15 parts of pangolin scales (concoction), 5 to 15 parts of common burreed rhizome, 10 to 20 parts of zedoary, 25 to 35 parts of calcined oyster shell, 5 to 15 parts of scrophularia root, 6 to 18 parts of root of red-rooted salvia, 6 to 18 parts of dipsacus root, 5 to 15 parts of poria, 5 to 15 parts of panax notoginseng, 5 to 15 parts of kelp, 15 to 25 parts of european verbena, 5 to 15 parts of cowherb seed, 5 to 15 parts of Indian iphigenia bulb and 5 to 15 parts of brittle falsepimpernel herb; and the preparation for external application comprises the following components in part by weight: 4 to 16 parts of nux vomica, 5 to 15 parts of pnus massoniana leaf, 5 to 17 parts of siam psychotria leaf, 4 to 15 parts of bead tree leaf, 3 to 16 parts of whiteflower leadword root leaf, 5 to 16 parts of common jasminorange leaf and twig and 4 to 17 parts of glechoma hederacea L. The Chinese medicinal compound preparation for treating the uterine myoma has the advantages of short course of treatment, definite and obvious curative effect and no side effect by applying the pharmacology and medicinal effect of the oral administration and external application of traditional Chinese medicines.

Description

technical field [0001] The invention relates to a traditional Chinese medicine compound preparation for treating uterine fibroids. Background technique [0002] Uterine fibroids are the most common benign tumors in the female reproductive organs. It is formed by the proliferation of uterine smooth muscle cells, which contains a small amount of fibrous connective tissue, but it is not the basic component of fibroids, so its exact diagnosis should be "uterine leiomyoma", commonly known as "uterine fibroids". The clinical manifestations of uterine fibroids often vary with the location, size, growth rate, secondary degeneration, and complications of the fibroids. Clinically, many patients are asymptomatic and are only discovered occasionally during pelvic examination, about 20% -50% The common symptoms of fibroids are uterine bleeding, abdominal mass, pain, compression symptoms of adjacent organs, increased leucorrhea, infertility, secondary anemia and cardiac dysfunction. The...

AI Technical Summary

Problems solved by technology

[0004] 1. Among the hormones, Kessin Pills smg, take orally or intramuscularly inject 251ng of Kessine Propionate Pills, the total amount of each month should not exceed 300mg, clinical observation, choose this medicine, and it has side effects